Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs

A patient who has achieved resolution of acute hepatitis B and acquired anti-HBs would get protective immunity against hepatitis B virus (HBV). However, reactivation of HBV could happen if the patient was exposed to an immunocompromised state by using immunosuppressive drugs or chemotherapeutic agen...

Full description

Bibliographic Details
Main Authors: Doh Hyung Kim, Seok Bae Kim
Format: Article
Language:English
Published: Karger Publishers 2018-06-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:https://www.karger.com/Article/FullText/490099
_version_ 1811224728566759424
author Doh Hyung Kim
Seok Bae Kim
author_facet Doh Hyung Kim
Seok Bae Kim
author_sort Doh Hyung Kim
collection DOAJ
description A patient who has achieved resolution of acute hepatitis B and acquired anti-HBs would get protective immunity against hepatitis B virus (HBV). However, reactivation of HBV could happen if the patient was exposed to an immunocompromised state by using immunosuppressive drugs or chemotherapeutic agents. That is because cccDNA could reside within hepatocytes after recovery of acute hepatitis B. Therefore, guidelines for hepatitis B recommend the use of prophylactic antiviral agents such as entecavir or tenofovir in patients with anti-HBc IgG. The reactivation of hepatitis B without exposure to an immunocompromised state is very rare and only 1 case has been reported in the world to date. An 82-year-old male patient visited Dankook University Hospital because of high aspartate transaminase, alanine aminotransferase, and total bilirubin. He had shown HBsAg negative/anti-HBs positive when he had blood test examinations 1 year previously. However, the present blood test revealed HBsAg positive/anti-HBs negative and a high titer of HBV DNA (814,815 copies/mL). He had undergone vertebroplasty 5 years previously and had no other medical history. Other blood and radiological examinations failed to show other diseases that could affect host immunity. He started antiviral treatment with entecavir. However, he passed away because of deteriorated hepatic function and hepatorenal syndrome 20 days after admission. It is very rare that a patient with anti-HBs would develop hepatic failure and pass away without trigger factors. Here, we report the case with a literature review.
first_indexed 2024-04-12T08:54:32Z
format Article
id doaj.art-fdd0fac90641421fa460a3d2abf12288
institution Directory Open Access Journal
issn 1662-0631
language English
last_indexed 2024-04-12T08:54:32Z
publishDate 2018-06-01
publisher Karger Publishers
record_format Article
series Case Reports in Gastroenterology
spelling doaj.art-fdd0fac90641421fa460a3d2abf122882022-12-22T03:39:28ZengKarger PublishersCase Reports in Gastroenterology1662-06312018-06-0112228629110.1159/000490099490099Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBsDoh Hyung KimSeok Bae KimA patient who has achieved resolution of acute hepatitis B and acquired anti-HBs would get protective immunity against hepatitis B virus (HBV). However, reactivation of HBV could happen if the patient was exposed to an immunocompromised state by using immunosuppressive drugs or chemotherapeutic agents. That is because cccDNA could reside within hepatocytes after recovery of acute hepatitis B. Therefore, guidelines for hepatitis B recommend the use of prophylactic antiviral agents such as entecavir or tenofovir in patients with anti-HBc IgG. The reactivation of hepatitis B without exposure to an immunocompromised state is very rare and only 1 case has been reported in the world to date. An 82-year-old male patient visited Dankook University Hospital because of high aspartate transaminase, alanine aminotransferase, and total bilirubin. He had shown HBsAg negative/anti-HBs positive when he had blood test examinations 1 year previously. However, the present blood test revealed HBsAg positive/anti-HBs negative and a high titer of HBV DNA (814,815 copies/mL). He had undergone vertebroplasty 5 years previously and had no other medical history. Other blood and radiological examinations failed to show other diseases that could affect host immunity. He started antiviral treatment with entecavir. However, he passed away because of deteriorated hepatic function and hepatorenal syndrome 20 days after admission. It is very rare that a patient with anti-HBs would develop hepatic failure and pass away without trigger factors. Here, we report the case with a literature review.https://www.karger.com/Article/FullText/490099Hepatitis B virusReactivationHepatic failureResolution
spellingShingle Doh Hyung Kim
Seok Bae Kim
Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs
Case Reports in Gastroenterology
Hepatitis B virus
Reactivation
Hepatic failure
Resolution
title Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs
title_full Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs
title_fullStr Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs
title_full_unstemmed Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs
title_short Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs
title_sort hepatic failure by spontaneous reactivation of hepatitis b virus without a trigger factor in a patient with anti hbs
topic Hepatitis B virus
Reactivation
Hepatic failure
Resolution
url https://www.karger.com/Article/FullText/490099
work_keys_str_mv AT dohhyungkim hepaticfailurebyspontaneousreactivationofhepatitisbviruswithoutatriggerfactorinapatientwithantihbs
AT seokbaekim hepaticfailurebyspontaneousreactivationofhepatitisbviruswithoutatriggerfactorinapatientwithantihbs